These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 35473846

  • 1. Modification of the ALSFRS-R for Utilization in Individuals Not Using Noninvasive Ventilation.
    Vlok L, Rossouw L, Henning F.
    Respir Care; 2022 May; 67(5):553-561. PubMed ID: 35473846
    [Abstract] [Full Text] [Related]

  • 2. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
    Prell T, Ringer TM, Wullenkord K, Garrison P, Gunkel A, Stubendorff B, Witte OW, Grosskreutz J.
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1022-6. PubMed ID: 27010615
    [Abstract] [Full Text] [Related]

  • 3. Daytime Mouthpiece for Continuous Noninvasive Ventilation in Individuals With Amyotrophic Lateral Sclerosis.
    Bédard ME, McKim DA.
    Respir Care; 2016 Oct; 61(10):1341-8. PubMed ID: 27354681
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis.
    Thakore NJ, Lapin BR, Pioro EP, Aboussouan LS.
    Neurology; 2019 Jul 16; 93(3):e306-e316. PubMed ID: 31182506
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life.
    Vandoorne E, Vrijsen B, Belge C, Testelmans D, Buyse B.
    Acta Clin Belg; 2016 Dec 16; 71(6):389-394. PubMed ID: 27112318
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A, De Mattia E, Lizio A, Sannicolò G, Carraro E, Rao F, Sansone V, Lunetta C.
    Clin Neurol Neurosurg; 2019 Sep 16; 184():105456. PubMed ID: 31382080
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of predictors of nocturnal hypoventilation in amyotrophic lateral sclerosis.
    Crescimanno G, Sorano A, Greco F, Canino M, Abbate A, Marrone O.
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb 16; 22(1-2):46-52. PubMed ID: 32897112
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.
    Donohue C, Chapin JL, Anderson A, DiBiase L, Gray LT, Wymer JP, Plowman EK.
    Muscle Nerve; 2023 Sep 16; 68(3):296-302. PubMed ID: 37345346
    [Abstract] [Full Text] [Related]

  • 13. Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent).
    Ando H, Ashcroft-Kelso H, Halhead R, Young CA, Chakrabarti B, Levene P, Cousins R, Angus RM.
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug 16; 20(5-6):336-347. PubMed ID: 30912468
    [Abstract] [Full Text] [Related]

  • 14. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
    Mehdipour A, Teshler L, Dal Bello-Haas V, Richardson J, Beauchamp M, Turnbull J, Chum M, Johnston W, O'Connell C, Luth W, Kuspinar A.
    Phys Ther; 2023 Nov 04; 103(11):. PubMed ID: 37581600
    [Abstract] [Full Text] [Related]

  • 15. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.
    Helleman J, Kruitwagen-van Reenen ET, Bakers J, Kruithof WJ, van Groenestijn AC, Jaspers Focks RJH, de Grund A, van den Berg LH, Visser-Meily JMA, Beelen A.
    J Neurol; 2020 Nov 04; 267(11):3310-3318. PubMed ID: 32577867
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors related to respiration influencing survival and respiratory function in patients with amyotrophic lateral sclerosis: a retrospective study.
    Leonardis L, Dolenc Grošelj L, Vidmar G.
    Eur J Neurol; 2012 Dec 04; 19(12):1518-24. PubMed ID: 22594630
    [Abstract] [Full Text] [Related]

  • 18. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M, Langford V, Holsten S, Rozario N, Patterson CGM, Bravver E, Bockenek WL, Brooks BR.
    Arch Phys Med Rehabil; 2017 Nov 04; 98(11):2301-2307. PubMed ID: 28465220
    [Abstract] [Full Text] [Related]

  • 19. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I, Dalla Bella E, Chiò A, Mora G, Filippini G, Lauria G, EPOS Trial Study Group.
    J Neurol Neurosurg Psychiatry; 2015 Nov 04; 86(11):1180-5. PubMed ID: 25886781
    [Abstract] [Full Text] [Related]

  • 20. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
    Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A.
    J Neurol Sci; 1999 Oct 31; 169(1-2):13-21. PubMed ID: 10540002
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.